Schlumberger, M <br/><br/>
Treatment of advanced medullary thyroid cancer with an alternating combination of 5 FU-streptozocin and 5 FU-dacarbazine. The Groupe d'Etude des Tumeurs a Calcitonine (GETC).  [electronic resource] 

 -  British journal of cancer  Feb 1995 
 - 363-5 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>0007-0920 
<br/><br/><label>Standard No.: </label>10.1038/bjc.1995.73  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Carcinoma, Medullary--drug therapy<br/>Combined Modality Therapy<br/>Dacarbazine--administration & dosage<br/>Drug Administration Schedule<br/>Female<br/>Fluorouracil--administration & dosage<br/>Humans<br/>Male<br/>Middle Aged<br/>Neoplasm Metastasis<br/>Palliative Care<br/>Radiotherapy, Adjuvant<br/>Streptozocin--administration & dosage<br/>Thyroid Neoplasms--drug therapy<br/>Thyroidectomy<br/>Treatment Outcome